Millions of women could soon have greater access to GLP-1 weight loss medications following the global effort to change the name of a hormonal condition that affects 1 in 8 women globally.  The condition, formerly known as Polycystic Ovarian Syndrome, or PCOS, recently underwent a name change following a years-long international effort, led by the […]
Millions of women could soon have greater access to GLP-1 weight loss medications following the global effort to change the name of a hormonal condition that affects 1 in 8 women globally.  The condition, formerly known as Polycystic Ovarian Syndrome, or PCOS, recently underwent a name change following a years-long international effort, led by the […]
<iframe src="https://statesidedaily.com/embed/cluster/4e2ce27614abb4d89ce4953f487772e05b4d760c" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Name tweak could boost GLP-1 access for one in eight women suffering PMOS"></iframe>
